Specialty
Cardiology (heart)
Conditions
Spoken Languages
English
Greek

Biography

Dr Vias Markides studied at Imperial College, London, qualifying in 1992 with distinction in all subjects and was awarded the University of London Gold Medal. 

He continued his training in a number of teaching centres in London, including St Mary’s, St Thomas’ and Hammersmith hospitals. 

In 2002, he was appointed as consultant cardiologist with an interest in arrhythmias and led the arrhythmia service on both sites of the Trust for ten years. The arrhythmia service has developed into the largest service of its type in the UK.   

Dr Markides has been a writing member for the National Service Framework for CHD (Chapter 8: Arrhythmias), and for a number of years was the clinical lead for arrhythmias/devices for the Northwest London Cardiovascular and Stroke Network, before taking overall leadership for cardiovascular services for the same network. He has played an important role in the shaping and delivery of a novel model of care for arrhythmias in London.

Areas of expertise

Dr Markides specialises in the management of all arrhythmias, but especially ablation for complex arrhythmias. This includes: 

  • atrial fibrillation
  • ventricular tachycardia
  • implantation of pacemakers, ICDs and devices for cardiac resynchronisation.

He was appointed as director of the heart division at Royal Brompton Hospital in October 2014. 

Research interests

His research interests include: 

  • complex arrhythmia mapping
  • atrial fibrillation
  • endocardial left ventricular pacing for cardiac resynchronisation.

Private patient referral 

If you would like to make an appointment with this specialist for private care, contact the RB&HH Specialist care team


Research Publications

BACKGROUND Atrial fibrillation is common in advanced heart failure, but its prognostic significance is controversial.

The new edition of Electrophysiological Disorders of the Heart helps you diagnose and treat a full range of heart rhythm disorders using today’s latest technologies and therapies.